Qiagen Reports 13 Percent Q3 Revenue Growth on Strong Molecular Dx Sales | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen reported after markets closed yesterday that its third-quarter revenues increased 13 percent and its profit rose 81 percent, both of which exceeded guidance provided by the company in the wake of its second-quarter financial results.

Qiagen logged total revenues of $259.7 million in the third quarter of 2009 compared to $230.8 million in the same quarter last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.